Inari Medical Inc (NARI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | NARI | TMO | ISRG | EW | IDXX |
| Company | Inari Medical Inc | Thermo Fisher Scientific Inc | Intuitive Surg Inc | Edwards Lifesciences Corp | Idexx Laboratories |
| Price Information | |||||
| Exchange | NASDAQ | NYSE | NASDAQ | NYSE | NASDAQ |
| Open | 37.95 | 567.51 | 370.88 | 87.40 | 482.60 |
| High | 38.36 | 576.89 | 379.77 | 87.93 | 494.45 |
| Low | 36.81 | 560.00 | 368.68 | 86.76 | 481.49 |
| Last | 37.11 | 574.59 | 377.08 | 87.75 | 493.80 |
| Change | -0.82 | +26.21 | +8.15 | +0.79 | +14.23 |
| % Change | -2.16% | +4.78% | +2.21% | +0.91% | +2.97% |
| Volume | 1,534,800 | 2,543,900 | 1,858,700 | 2,663,600 | 558,400 |
| 20-Day Average Volume | 1,622,095 | 1,375,660 | 1,637,225 | 3,027,325 | 423,485 |
| Previous Close | 37.93 | 548.38 | 368.93 | 86.96 | 479.57 |
| Industry | Medical Instruments | Medical Instruments | Medical Instruments | Medical Instruments | Medical Instruments |
| Has Options | Yes | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 42.17 | 567.75 | 384.16 | 91.09 | 507.60 |
| 20-Day Raw Stochastic | 3.09% | 74.56% | 32.61% | 22.07% | 31.13% |
| 20-Day Relative Strength | 30.95% | 53.25% | 47.02% | 46.07% | 38.65% |
| Weighted Alpha | -50.15 | +8.23 | +27.05 | +6.20 | -0.93 |
| Today's Opinion | 100% Sell | 72% Buy | 40% Buy | 56% Buy | 40% Sell |
| Previous Opinion | 100% Sell | 24% Buy | 40% Buy | 56% Buy | 24% Sell |
| Last Month's Opinion | 100% Sell | 88% Buy | 100% Buy | 88% Buy | 56% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | -5.09% since 04/16/24 | +3.61% since 04/16/24 | -0.39% since 04/16/24 | -2.55% since 04/16/24 | +0.86% since 04/16/24 |
| Low | 36.73 on 04/22/24 | 529.64 on 04/18/24 | 364.17 on 04/19/24 | 85.38 on 04/19/24 | 471.42 on 04/19/24 |
| High | 39.78 on 04/17/24 | 576.89 on 04/23/24 | 388.65 on 04/19/24 | 89.89 on 04/17/24 | 494.45 on 04/23/24 |
| 1-Month | |||||
| %Chg | -16.27% since 03/22/24 | -1.46% since 03/22/24 | -4.31% since 03/22/24 | -6.44% since 03/22/24 | -6.96% since 03/22/24 |
| Low | 36.73 on 04/22/24 | 529.64 on 04/18/24 | 364.17 on 04/19/24 | 85.38 on 04/19/24 | 471.42 on 04/19/24 |
| High | 49.04 on 03/28/24 | 589.93 on 04/09/24 | 403.76 on 03/27/24 | 96.12 on 03/28/24 | 543.33 on 03/28/24 |
| 3-Month | |||||
| %Chg | -34.93% since 01/23/24 | +4.33% since 01/23/24 | +1.53% since 01/23/24 | +17.27% since 01/23/24 | -7.10% since 01/23/24 |
| Low | 36.73 on 04/22/24 | 529.64 on 04/18/24 | 362.14 on 01/24/24 | 71.92 on 01/25/24 | 471.42 on 04/19/24 |
| High | 59.54 on 02/15/24 | 603.82 on 03/08/24 | 403.76 on 03/27/24 | 96.12 on 03/28/24 | 583.39 on 03/01/24 |
| 6-Month | |||||
| %Chg | -35.40% since 10/23/23 | +24.42% since 10/23/23 | +38.33% since 10/23/23 | +27.08% since 10/23/23 | +15.45% since 10/23/23 |
| Low | 36.73 on 04/22/24 | 415.60 on 10/25/23 | 254.85 on 10/30/23 | 60.57 on 10/30/23 | 372.50 on 11/01/23 |
| High | 67.13 on 12/14/23 | 603.82 on 03/08/24 | 403.76 on 03/27/24 | 96.12 on 03/28/24 | 583.39 on 03/01/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 2,198,461 | 209,324,320 | 130,766,872 | 52,343,568 | 39,830,208 |
| Shares Outstanding, K | 57,961 | 381,714 | 354,449 | 601,927 | 83,054 |
| Annual Sales | 493,630,000 | 42,857,000,000 | 7,124,100,000 | 6,004,800,000 | 3,660,950,000 |
| Annual Net Income | -1,640,000 | 5,995,000,000 | 1,798,000,000 | 1,402,400,000 | 845,040,000 |
| Last Quarter Sales | 132,090,000 | 10,886,000,000 | 1,890,600,000 | 1,534,100,000 | 901,600,000 |
| Last Quarter Net Income | -4,670,000 | 1,630,000,000 | 544,900,000 | 369,900,000 | 194,520,000 |
| 60-Month Beta | 0.84 | 0.80 | 1.36 | 1.05 | 1.26 |
| Per-Share Information | |||||
| Most Recent Earnings | 0.05 on 02/28/24 | 5.67 on 01/31/24 | 1.50 on 04/18/24 | 0.64 on 02/06/24 | 2.32 on 02/05/24 |
| Latest Earnings Date | 04/30/24 | 04/24/24 | 04/18/24 | 04/25/24 | 05/01/24 |
| Most Recent Dividend | N/A | 0.390 on 03/14/24 | N/A | N/A | N/A |
| Next Ex-Dividends Date | N/A | 03/14/24 | N/A | N/A | N/A |
| Ratios | |||||
| Price/Earnings ttm | 385.90 | 25.29 | 78.28 | 34.24 | 47.30 |